The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010




During the past two decades, diabetes has become one of the most alarming public health problems. The rapid increase in the prevalence of obesity, type-2 diabetes and associated complications (diabesity) is a major global health problem worldwide.

Evolution suggests the inevitability of the passage of "thrifty genes" from generation to generation, providing protection during times of famine but predisposing the carriers of these genes to obesity and type 2 diabetes in times of plenty. The close relationship of obesity and type 2 diabetes with a cluster of cardiovascular risk factors has produced the terms "diabesity" and "metabolic syndrome."

Diabesity is a challenging condition that requires an integrated understanding of diabetes and obesity, as well as a coherent management plan that will drive forward effective measures for both prevention and intervention.

To prevent and treat diabesity, there is a need to develop approaches to modulate the ways in which the body controls metabolism, body weight and composition.

The conference brings together basic and clinical scientists aiming at identifying new factors implicated in obesity and diabetes, and to develop strategies for validating these factors as targets for future pharmacological manipulation, as well as identifying possibly several new drug targets for the treatment and prevention of diabesity. There is undoubtedly much still to learn about diabetes and obesity.


Alebiosu C. Olutayo
Olabisi Onabanjo University,
Sagamu, Ogun State, Nigeria.




 

Dr ALEBIOSU Christopher Olutayo BSc, MBChB, FWACP is a fellow of the West African Postgraduate Medical College and Reader in Medicine of the Olabisi Onabanjo University, Ago-Iwoye, Ogun State, Nigeria. He maintains the position as a Consultant Physician to the Teaching Hospital arm of the University. He is the Principal Investigator of the World Diabetes Foundation sponsored SIDCAIN Project in Nigeria (WDF08-321): the Strategies for Improving Diabetes Care in Nigeria. He has many scientific publications to his credit, mainly in the field of diabetic nephropathy, hypertension and nephrology. He has attended numerous scientific conferences both within and outside Nigeria.

His scientific contributions include over 70 invited lectures, presentations and publications. He distinguished himself in the first Nigerian Study on Clinico-pathological Study of Diabetic Nephropathy based on renal biopsy. Through one of his research publications, the home institution awarded him the Nigerian University Commission Award for indigenous research in 2004. He also won competitive training fellowship awards including World Diabetes Federation Fellowship / International Diabetes Federation Fellowship Award 2003 (Groote Schuur Hospital, University of Capetown, Republic of South Africa); International Society of Peritoneal dialysis Fellowship Training (2005) and IDF-BRIDGES Translational Research Grants Course, Ghana, 2008. He is a co-editor of, and contributor to the ‘Simplified complete handbook on diabetes’ published locally in 2007. He also co-authored a ‘Diabetes info booklet’ in the same year.

His scientific and professional activities include Fellow, West African College of Physicians (FWACP), Nigerian Medical Association, Director and Board Member, Diabetes Center of the Olabisi Onabanjo University; Executive Member, Nephrology Association of Nigeria, Editorial Board, Isegun Medical Journal and the Diabetes Association of Nigeria. He is a peer reviewer to over 15 local and international medical journals.

He is the Associate Professor of Medicine of the Olabisi Onabanjo University (formerly Ogun State University), Ago-Iwoye, Ogun State, and also the founding Director of the Diabetes Center affiliated to the University.

[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy